Human Neuropeptide Y

Human Neuropeptide Y

SCHEMBL29523348

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)[C@@H](C)CC

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 4/20 0.72
▸ NPY2R P49146 10/20 0.69
▸ NPY4R P50391 8/20 0.69
▸ NPY5R Q15761 8/20 0.69
▸ NPY1R P25929 8/20 0.69
▸ CRHR1 P34998 1/20 0.68
▸ CRHR2 Q13324 1/20 0.68
▸ GLP1R P43220 3/20 0.64
▸ GCGR P47871 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29496288 0.95 NPY2R (0.74) CALCRNPY2RNPY4RNPY5RNPY1R
Human Neuropeptide Y SCHEMBL29780330 0.94 NPY2R (0.79) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29571016 0.94 NPY2R (0.70) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29496391 0.94 NPY2R (0.72) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29440046 0.92 CRHR1 (0.77) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29526997 0.92 NPY2R (0.72) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL13248707 0.92 NPY2R (0.80) CALCRNPY2RNPY4RNPY5RNPY1R
Neuropeptide-Y SCHEMBL3051623 0.91 NPY2R (0.82) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29570760 0.91 NPY2R (0.69) CALCRNPY2RNPY4RNPY5RNPY1R
SCHEMBL29975560 0.91 NPY2R (0.69) CALCRNPY2RNPY4RNPY5RNPY1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12551533-B2 Intranasal neuropeptides for use in stress-related impairments NEW YORK MEDICAL COLLEGE (US) 2026-02-17 — — US disclosed
US-20220143147-A1 INTRANASAL NEUROPEPTIDES FOR USE IN STRESS-RELATED IMPAIRMENTS NEW YORK MEDICAL COLLEGE 2022-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12551533-B2 Intranasal neuropeptides for use in stress-related impairments NPY5R, NPY1R, NPY2R CALCR 1093/4885NPY2R 3/4885NPY4R 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback